Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Eton Pharmaceuticals, Inc. Common Stock
IPO Date: November 13, 2018
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Cap: $386.98M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 2.77%
Avg Daily Range (30 D): $0.36 | 2.45%
Avg Daily Range (90 D): $0.45 | 2.96%
Institutional Daily Volume
Avg Daily Volume: .2M
Avg Daily Volume (30 D): .43M
Avg Daily Volume (90 D): .33M
Trade Size
Avg Trade Size (Sh.): 123
Avg Trade Size (Sh.) (30 D): 67
Avg Trade Size (Sh.) (90 D): 67
Institutional Trades
Total Inst.Trades: 33
Avg Inst. Trade: $2.31M
Avg Inst. Trade (30 D): $3.3M
Avg Inst. Trade (90 D): $2.79M
Avg Inst. Trade Volume: .21M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $4.81M
Avg Closing Trade (30 D): $5.83M
Avg Closing Trade (90 D): $5.11M
Avg Closing Volume: 436.89K
   
News
May 9, 2024 @ 8:01 PM
Eton Pharmaceuticals Reports First Quarter 2024 Fi...
Source: Eton Pharmaceuticals
May 1, 2024 @ 8:05 PM
Eton Pharmaceuticals to Present at the Citizens JM...
Source: Eton Pharmaceuticals
Apr 30, 2024 @ 11:00 AM
Eton Pharmaceuticals Announces Submission to FDA o...
Source: Eton Pharmaceuticals
Apr 29, 2024 @ 8:30 PM
Eton Pharmaceuticals to Report First Quarter 2024 ...
Source: Eton Pharmaceuticals
Mar 22, 2024 @ 6:00 AM
Eton Pharmaceuticals Announces Acquisition of PKU...
Source: Eton Pharmaceuticals
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.19 $-.06 $-.03
Diluted EPS
Revenue $ 48.33M $ 17.28M $ 11.65M
Gross Profit $ 28.27M $ 9.86M $ 6.48M
Net Income / Loss $ -4.58M $ -1.57M $ -.6M
Operating Income / Loss $ -2.27M $ -.47M $ .63M
Cost of Revenue $ 20.06M $ 7.42M $ 5.17M
Net Cash Flow $ -1.72M $ M $ -5.33M
PE Ratio